Novo Nordisk A/S investors got a much-needed boost from last week’s trial results for an experimental weight-loss shot. But ...
It’s a problem that has plagued European governments for decades, from the credit-crunch bank bailouts of 2008 to more recent ...
Drug manufacturer Novo Nordisk's amycretin, an experimental weight-loss pill in clinical trials, may boast substantial weight ...
The top 20 biopharmaceutical companies experienced mixed performance in 2024 amid a dynamic landscape influenced by various ...
European shares were at a record high on Friday, led by technology and healthcare stocks, even as caution prevailed ahead of ...
Analysts predict the weight loss drug market to grow between $100 billion and $130 billion by 2030, as per a report.
Your favorite toys and weight-loss drugs could be priced out of reach if Donald Trump is serious. Denmark’s defiant message ...
Live HealthSmart Alabama is a University of Alabama at Birmingham initiative that is making a difference in the Black Belt.
A daily rundown of the economic reports and corporate earnings that will be grabbing the market’s attention in the week ahead ...
We recently compiled a list of the Jim Cramer Discussed These 12 Stocks Amidst The DeepSeek AI Selloff. In this article, we ...
More than half of adults with overweight or obesity prescribed a GLP-1 discontinue their drug within 1 year, with discontinuation rates higher for those without type 2 diabetes, researchers reported ...
Pharmapack wrapped up last week with two full days of new product innovation, networking, and informative talks, sessions, ...